REFERENCES
1. Chung KF, Adcock IM. Precision medicine for the discovery of
treatable mechanisms in severe asthma. Allergy. 2019;74(9):1649-59.
2. Buhl R, Humbert M, Bjermer L, Chanez P, Heaney LG, Pavord I, et al.
Severe eosinophilic asthma: a roadmap to consensus. Eur Respir J.
2017;49(5).
3. Kuo CS, Pavlidis S, Loza M,
Baribaud F, Rowe A, Pandis I, et al. T-helper cell type 2 (Th2) and
non-Th2 molecular phenotypes of asthma using sputum transcriptomics in
U-BIOPRED. Eur Respir J. 2017;49(2): 1602135 .
4. Simpson JL, Phipps S, Baines KJ, Oreo KM, Gunawardhana L, Gibson PG.
Elevated expression of the NLRP3 inflammasome in neutrophilic asthma.
Eur Respir J. 2014;43(4):1067-76.
5. Budden KF, Shukla SD, Rehman SF, Bowerman KL, Keely S, Hugenholtz P,
et al. Functional effects of the microbiota in chronic respiratory
disease. The lancet Respiratory medicine. 2019;7(10):907-20.
6. Chung KF. Potential Role of the Lung Microbiome in Shaping Asthma
Phenotypes. Annals of the American Thoracic Society.
2017;14(Supplement_5):S326-S31.
7. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, et al.
Disordered microbial communities in asthmatic airways. PloS one.
2010;5(1):e8578.
8. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, et al.
Airway microbiota and bronchial hyperresponsiveness in patients with
suboptimally controlled asthma. J Allergy Clin Immunol.
2011;127(2):372-81.e1-3.
9. Green BJ, Wiriyachaiporn S, Grainge C, Rogers GB, Kehagia V, Lau L,
et al. Potentially pathogenic airway bacteria and neutrophilic
inflammation in treatment resistant severe asthma. PloS one.
2014;9(6):e100645.
10. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB,
Bonnelykke K, et al. Childhood asthma after bacterial colonization of
the airway in neonates. N Engl J Med. 2007;357(15):1487-95.
11. Huang YJ, Nariya S, Harris JM, Lynch SV, Choy DF, Arron JR, et al.
The airway microbiome in patients with severe asthma: Associations with
disease features and severity. J Allergy Clin Immunol.
2015;136(4):874-84.
12. Simpson JL, Daly J, Baines KJ, Yang IA, Upham JW, Reynolds PN, et
al. Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly
controlled asthma. Eur Respir J. 2016;47(3):792-800.
13. Taylor SL, Leong LEX, Choo JM, Wesselingh S, Yang IA, Upham JW, et
al. Inflammatory phenotypes in patients with severe asthma are
associated with distinct airway microbiology. J Allergy Clin Immunol.
2018;141(1):94-103 e15.
14. Kuo CS, Pavlidis S, Loza M, Baribaud F, Rowe A, Pandis I, et al.
T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma
using sputum transcriptomics in U-BIOPRED. Eur Respir J.
2017;49(2):443-55.
15. Shaw DE, Sousa AR, Fowler SJ, Fleming LJ, Roberts G, Corfield J, et
al. Clinical and inflammatory characteristics of the European U-BIOPRED
adult severe asthma cohort. Eur Respir J. 2015;46(5):1308-21.
16. Rossios C, Pavlidis S, Hoda U, Kuo CH, Wiegman C, Russell K, et al.
Sputum transcriptomics reveal upregulation of IL-1 receptor family
members in patients with severe asthma. J Allergy Clin Immunol.
2018;141(2):560-70.
17. Andrew S. FastQC: A Quality Control Tool for High Throughput
Sequence Data [Online]. 2010.
18. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2.
Nature methods. 2012;9(4):357-9.
19. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The
Sequence Alignment/Map format and SAMtools. Bioinformatics (Oxford,
England). 2009;25(16):2078-9.
20. Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for
comparing genomic features. Bioinformatics (Oxford, England).
2010;26(6):841-2.
21. Morgan M, Anders S, Lawrence M, Aboyoun P, Pagès H, Gentleman R.
ShortRead: a bioconductor package for input, quality assessment and
exploration of high-throughput sequence data. Bioinformatics (Oxford,
England). 2009;25(19):2607-8.
22. Truong DT, Franzosa EA, Tickle TL, Scholz M, Weingart G, Pasolli E,
et al. MetaPhlAn2 for enhanced metagenomic taxonomic profiling. Nature
methods. 2015;12(10):902-3.
23. Morgat A, Coissac E, Coudert E, Axelsen KB, Keller G, Bairoch A, et
al. UniPathway: a resource for the exploration and annotation of
metabolic pathways. Nucleic Acids Res. 2012;40(Database issue):D761-9.
24. Oksanen J, Blanchet, F.G., Friendly,M., Kindt, R. , Legendre,P.
McGlinn, D. Minchin,P.R. O’Hara, R.B. Simpson, G.L. Solymos, P. Stevens,
M.H.M. Szoecs, E. Wagner, H. Ordination methods, diversity analysis and
other functions for community and vegetation ecologists. 2017.
25. McMurdie PJ, Holmes S. phyloseq: an R package for reproducible
interactive analysis and graphics of microbiome census data. PloS one.
2013;8(4):e61217.
26. Love MI, Huber W, Anders S. Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
27. Liang Z, Zhang Q, Thomas CM, Chana KK, Gibeon D, Barnes PJ, et al.
Impaired macrophage phagocytosis of bacteria in severe asthma.
Respiratory research. 2014;15:72.
28. Clemans DL, Bauer RJ, Hanson JA, Hobbs MV, St Geme JW, 3rd, Marrs
CF, et al. Induction of proinflammatory cytokines from human respiratory
epithelial cells after stimulation by nontypeable Haemophilus
influenzae. Infect Immun. 2000;68(8):4430-40.
29. Galdiero M, Galdiero M, Finamore E, Rossano F, Gambuzza M, Catania
MR, et al. Haemophilus influenzae porin induces Toll-like receptor
2-mediated cytokine production in human monocytes and mouse macrophages.
Infect Immun. 2004;72(2):1204-9.
30. Hassan F, Ren D, Zhang W, Merkel TJ, Gu XX. Moraxella catarrhalis
activates murine macrophages through multiple toll like receptors and
has reduced clearance in lungs from TLR4 mutant mice. PloS one.
2012;7(5):e37610.
31. Fink J, Mathaba LT, Stewart GA, Graham PT, Steer JH, Joyce DA, et
al. Moraxella catarrhalis stimulates the release of proinflammatory
cytokines and prostaglandin E from human respiratory epithelial cells
and monocyte-derived macrophages. FEMS Immunol Med Microbiol.
2006;46(2):198-208.
32. N’Guessan PD, Temmesfeld-Wollbrück B, Zahlten J, Eitel J, Zabel S,
Schmeck B, et al. Moraxella catarrhalis induces ERK- and
NF-kappaB-dependent COX-2 and prostaglandin E2 in lung epithelium. Eur
Respir J. 2007;30(3):443-51.
33. Bousbia S, Papazian L, Auffray JP, Fenollar F, Martin C, Li W, et
al. Tropheryma whipplei in patients with pneumonia. Emerg Infect Dis.
2010;16(2):258-63.
34. Lozupone C, Cota-Gomez A, Palmer BE, Linderman DJ, Charlson ES,
Sodergren E, et al. Widespread colonization of the lung by Tropheryma
whipplei in HIV infection. Am J Respir Crit Care Med.
2013;187(10):1110-7.
35. Erb-Downward JR, Thompson DL, Han MK, Freeman CM, McCloskey L,
Schmidt LA, et al. Analysis of the lung microbiome in the “healthy”
smoker and in COPD. PloS one. 2011;6(2):e16384.
36. Morris A, Beck JM, Schloss PD, Campbell TB, Crothers K, Curtis JL,
et al. Comparison of the respiratory microbiome in healthy nonsmokers
and smokers. Am J Respir Crit Care Med. 2013;187(10):1067-75.
37. Lim MY, Yoon HS, Rho M, Sung J, Song YM, Lee K, et al. Analysis of
the association between host genetics, smoking, and sputum microbiota in
healthy humans. Scientific reports. 2016;6:23745.
38. Denner DR, Sangwan N, Becker JB, Hogarth DK, Oldham J, Castillo J,
et al. Corticosteroid therapy and airflow obstruction influence the
bronchial microbiome, which is distinct from that of bronchoalveolar
lavage in asthmatic airways. J Allergy Clin Immunol.
2016;137(5):1398-405 e3.
39. Goleva E, Jackson LP, Harris JK, Robertson CE, Sutherland ER, Hall
CF, et al. The effects of airway microbiome on corticosteroid
responsiveness in asthma. Am J Respir Crit Care Med.
2013;188(10):1193-201.
40. Abdel-Aziz MI, Brinkman P, Vijverberg SJH, Neerincx AH, Riley JH,
Bates S, et al. Sputum microbiome profiles identify severe asthma
phenotypes of relative stability at 12 to 18 months. Journal of Allergy
and Clinical Immunology. 2021;147(1):123-34.
41. Kim YH, Jang H, Kim SY, Jung JH, Kim GE, Park MR, et al.
Gram-negative microbiota is related to acute exacerbation in children
with asthma. Clinical and translational allergy. 2021;11(8):e12069.
42. Abdel-Aziz MI, Vijverberg SJH, Neerincx AH, Brinkman P, Wagener AH,
Riley JH, et al. A multi-omics approach to delineate sputum
microbiome-associated asthma inflammatory phenotypes. Eur Respir J.
2022;59(1).
43. Menzel P, Ng KL, Krogh A. Fast and sensitive taxonomic
classification for metagenomics with Kaiju. Nat Commun. 2016;7:11257.